UnitedHealth Group (NYSE:UNH – Get Rating) updated its FY22 earnings guidance on Friday. The company provided earnings per share guidance of $21.85-22.05 for the period, compared to the consensus earnings per share estimate of $21.89. UnitedHealth Group also updated its FY 2022 guidance to $21.85-$22.05 EPS.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on UNH. UBS Group upped their target price on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a neutral rating in a research note on Thursday, July 21st. BMO Capital Markets upped their target price on shares of UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Mizuho boosted their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a buy rating in a report on Wednesday, August 10th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $556.00 to $569.00 and gave the stock a buy rating in a report on Thursday, September 8th. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $586.40.
UnitedHealth Group Stock Up 2.0 %
Shares of NYSE UNH opened at $509.91 on Friday. UnitedHealth Group has a one year low of $417.80 and a one year high of $553.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The firm’s 50 day simple moving average is $523.82 and its two-hundred day simple moving average is $513.68. The stock has a market capitalization of $476.96 billion, a P/E ratio of 26.63, a PEG ratio of 1.57 and a beta of 0.75.
UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings data on Friday, October 14th. The healthcare conglomerate reported $5.79 earnings per share for the quarter, beating analysts’ consensus estimates of $5.45 by $0.34. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm had revenue of $80.89 billion during the quarter, compared to analyst estimates of $80.54 billion. During the same quarter in the prior year, the firm posted $4.52 earnings per share. The business’s quarterly revenue was up 11.8% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group will post 21.86 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were given a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a yield of 1.29%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s dividend payout ratio is currently 34.46%.
Insider Buying and Selling at UnitedHealth Group
In other news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the sale, the chief executive officer now owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 139,051 shares of company stock valued at $74,450,958. 0.40% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On UnitedHealth Group
A number of large investors have recently made changes to their positions in UNH. Arrowstreet Capital Limited Partnership grew its stake in shares of UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after purchasing an additional 2,540,538 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of UnitedHealth Group by 2.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 5,147,368 shares of the healthcare conglomerate’s stock valued at $2,625,004,000 after buying an additional 132,461 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of UnitedHealth Group by 31.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after buying an additional 60,300 shares in the last quarter. Sculptor Capital LP lifted its position in shares of UnitedHealth Group by 13.5% during the 1st quarter. Sculptor Capital LP now owns 498,807 shares of the healthcare conglomerate’s stock valued at $254,377,000 after buying an additional 59,359 shares in the last quarter. Finally, Mariner LLC lifted its position in shares of UnitedHealth Group by 15.3% during the 1st quarter. Mariner LLC now owns 423,948 shares of the healthcare conglomerate’s stock valued at $216,206,000 after buying an additional 56,195 shares in the last quarter. 87.25% of the stock is currently owned by institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and UnitedHealth Group wasn’t on the list.
While UnitedHealth Group currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Techyrack Website stock market day trading and youtube monetization and adsense Approval
Adsense Arbitrage website traffic Get Adsense Approval Google Adsense Earnings Traffic Arbitrage YouTube Monetization YouTube Monetization, Watchtime and Subscribers Ready Monetized Autoblog
Keine Kommentare:
Kommentar veröffentlichen